CTOs on the Move

Apos Therapy

www.apostherapy.com

 
AposTherapy provides a clinically proven, innovative, drug-free, at-home treatment for reducing pain and improving function in patients suffering from knee osteoarthritis and chronic lower back or hip pain.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Apos Therapy raised $11M on 02/17/2020

Similar Companies

Boston MicroFluidics

Boston Microfluidics (BMF) is dedicated to connecting people to their health by increasing access to diagnostic testing for all people. Our technology is a unique combination of elegant sample processing solutions with an intuitive user interface. We strive to streamline current testing systems with devices that perform complex sample processing steps without the need for trained professionals or specialized laboratory equipment. We also seek to simplify diagnostic tests so that they can be used efficiently at the point of care, or even be available for direct sale to consumers. Above all, BMF works to help provide patients with the information they need to make choices about their health.

Health Care Financing Administration

Health Care Financing Administration is a Gwynn Oak, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Humacyte

Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.

Saint John's Health System

Saint John's Health System is a Anderson, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Daniel Jarvis Home Health Private

Daniel Jarvis Home Health Private is a Bryan, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.